Seattle, WA, United States of America

Reitha S Weeks

This inventor holds 1 USPTO granted patent. Top assignee: Mediquest Therapeutics, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reitha S Weeks. Retrieved from https://idiyas.com/inventor/reitha-s-weeks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reitha S. Weeks: Innovator in Polyamine Transport Inhibition

Introduction

Reitha S. Weeks is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of medical science, particularly in the treatment of proliferative cutaneous diseases. Her innovative work has led to the development of a unique composition that utilizes polyamine transport inhibitors.

Latest Patents

Reitha holds 1 patent for her invention titled "Composition containing polyamine transport inhibitor and use thereof." This patent addresses the treatment of proliferative cutaneous disease states or conditions by administering a polyamine transport inhibitor.

Career Highlights

Reitha is currently associated with Mediquest Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is pivotal in exploring new therapeutic avenues for skin-related conditions.

Collaborations

Reitha has collaborated with esteemed colleagues, including Mark R. Burns and Gerard F. Graminski, who contribute to her innovative projects and research initiatives.

Conclusion

Reitha S. Weeks exemplifies the spirit of innovation in the medical field, with her groundbreaking work on polyamine transport inhibitors paving the way for new treatments. Her contributions are invaluable to the advancement of therapeutic solutions for skin diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…